Publication | Closed Access

Use and specificity of breast cancer antigen/milk protein BA46 for generating anti-self-cytotoxic T lymphocytes by recombinant adeno-associated virus-based gene loading of dendritic cells

Cancer ImmunosurveillanceImmunologyTumor ImmunityDendritic CellsAnti-self-cytotoxic T LymphocytesTherapeutic VaccineT Cell ImmunityBreast CancerVaccine DesignImmunotherapyMedicineCell BiologySynthetic ImmunologyBreast Cancer Antigen/milk